New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia
The Magic Mushrooms and MDMA market is hitting new milestones. Canada has licensed Optimi Health Corp. (OTC:OPTHF) to export psilocybin and MDMA to Australia, marking a significant step in the medical psychedelic drugs market. This license allows the Vancouver-based startup to ship controlled substances for patient use. This development positions Optimi among a select group of legal international suppliers of psychedelic drugs, aiming to become a relevant player in the manufacture of pharmaceutical-grade psychs.
Industry Impact and Investment
Optimi Health’s vision focuses on the potential of psychedelics as alternatives to traditional pharmaceuticals for mental health treatment. The company has invested heavily in setting up 20,000 square feet of facilities in Princeton, British Columbia, designed to meet stringent quality standards.
Co-founder J.J. Wilson, son of Lululemon Athletica (NASDAQ: LULU) founder Chip Wilson, who also sits on the board, emphasizes that the demand for pharmaceutical-grade psychedelics will be robust. “The world is taking this more seriously as an …